NewsBenzingaArtelo Biosciences Files Provisional Patent Application For ART27.13 As Monotherapy And In Combination With GLP-1 Receptor Agonists Artelo Biosciences Files Provisional Patent Application For ART27.13 As Monotherapy And In Combination With GLP-1 Receptor Agonists Benzinga 2026.09.23 11:35 (GMT+0) Open on Benzinga Other news What's Going On With Super Micro Computer Stock Thursday? What's Going On with Lucid Stock Thursday? RBC Capital Reiterates Outperform on Meta Platforms, Maintains $770 Price Target Canaccord Genuity Maintains Buy on Worthington Enterprises, Raises Price Target to $75 Reported Earlier: Jaguar Health Issues 547,898 Common Shares To Streeterville Capital To Retire ~$5.05M Of Outstanding Promissory Note RBC Capital Maintains Sector Perform on McDonald's, Lowers Price Target to $285
Reported Earlier: Jaguar Health Issues 547,898 Common Shares To Streeterville Capital To Retire ~$5.05M Of Outstanding Promissory Note
